Alternatives to Amicus Therapeutics
Amicus Therapeutics is a Biotech tool: biotechnology company focused on developing treatments for rare metabolic diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Amicus Therapeutics
- Website
Travere Therapeutics51BiotechnologySan Diego, USA$63.0MA biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
- Website
Regenxbio55BiotechRockville, United States$180.0MClinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.
- Website
Harmony Biosciences Holdings57BiotechPlymouth Meeting, United States$400.5MBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
- Website
Avidity Biosciences53BiotechSan Diego, United States$495.0MClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
- Website
Rezolute52BiotechRedwood City, United States$220.0MBiopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.
- Website
Orchard Therapeutics51BiotechBoston, United States$125.0MGene therapy company developing treatments for rare inherited diseases.
- Website
Editas Medicine42BiotechCambridge, United States$210.0MA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
- Website
Intellia Therapeutics40BiotechCambridge, United States$310.0MA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
- Website
Lutris Pharma39BiotechSan Diego, United States$170.0MLutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.
- Website RHRhythm Pharmaceuticals61BiotechBoston, United States
Biopharmaceutical company focused on rare genetic diseases of obesity.
- Website
Gene Bio Medical36BiotechTel Aviv, Israel$10.0MDevelops advanced gene editing and cell therapy solutions for rare genetic diseases.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Synthace62BiotechLondon, United Kingdom$60.6MSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
ImCheck Therapeutics60BiotechMarseille, France$164.0MImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website
Mustang Bio41BiotechWorcester, United StatesClinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.
Showing the 20 closest matches. See the rest on the Amicus Therapeutics profile.
Compare Amicus Therapeutics head to head
Side by side on what each one does, what it costs, and what real users report.